Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 182

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 182
---
 as an additional director. A director is not subject to a term
of office and shall hold office until he or she is removed or resigned in accordance with our Amended and Restated Memorandum and Articles
of Association, unless such director is appointed on such express terms that he or she shall automatically retire from office (unless
he or she has sooner vacated office) at the next or a subsequent annual general meeting or upon any specified event or after any specified
period.

A director may be removed by an ordinary resolution
of our shareholders. A director's office will also be terminated automatically if, among other things, the director (i) becomes
bankrupt or makes any arrangement or composition with his creditors, (ii) resigns his office by notice to the Company, (iv) without
the consent of the other directors, is absent from meetings of our board for a continuous period of six months, or (v) in the
opinion of a registered medical practitioner by whom he is being treated he becomes physically or mentally incapable of acting as a director.

Qualification

There is currently no shareholding qualification for directors, although a shareholding qualification for directors may be fixed by our shareholders by ordinary resolution.

<div align='center'>102</div>

Insider Participation Concerning Executive Compensation

Our board of directors, which currently consists of Ka Lun To and Shing Hei Lee and will also consist of three independent directors whose appointments will be effective as of the effectiveness of the registration statement of which this prospectus forms a part, is making all determinations regarding executive officer compensation from the time the Company first entered into employment agreements with executive officers up until the time where the three independent directors will be installed.

Committees of the Board of Directors

We will establish three committees under the board of directors immediately upon the effectiveness of the registration statement of which this prospectus forms a part: an audit committee, a compensation committee and a nominating and corporate governance committee. Even though we are exempted from corporate governance standards because we are a foreign private issuer, we have voluntarily adopted a charter for each of the three committees. Each committee’s members and functions are described below.

Audit Committee. Our audit committee will consist of Kenrick B Toussaint, Chun Fai Fong, and Bin Zhou. Kenrick B Toussaint will be the chairman of our audit committee. We have determined that Kenrick B Toussaint, Chun Fai Fong, and Bin Zhou will satisfy the “independence” requirements of Section 5605